Mortality in Paediatric Intensive Care (Paedmort)

March 23, 2023 updated by: Petr Štourač, MD, Brno University Hospital

Mortality in Tertiary Paediatric Critical Care Centre 2008-2012 Versus 2013-2017: Retrospective Cohort Trial

Mortality of paediatric patients in intensive care can be considered as on of the parameters of quality of care. Together with the advance in research and medicine there should be a trend towards mortality reduction, however actual data in Czech Republic are not well documented. The aim of this retrospective cohort trial was to evaluate the mortality of paediatric intensive care patients admitted to Department of paediatric anaesthesiology and intensive care between two periods 2008-2012 and 2013 and 2017

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Mortality of paediatric patients in intensive care can be considered as on of the parameters of quality of care. Together with the advance in research and medicine there should be a trend towards mortality reduction, however actual data in Czech Republic are not well documented. The aim of this retrospective cohort trial was to evaluate the mortality of paediatric intensive care patients admitted to Department of paediatric anaesthesiology and intensive care between two periods 2008-2012 and 2013 and 2017. The patients records was retrospectively searched and the mortality was adjusted according to the primary admission diagnosis.

Study Type

Observational

Enrollment (Anticipated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Paediatric patients admitted to the intensive care in selected period (2008-2012. versus 2013-2017).

Description

Inclusion Criteria:

  • Pediatric patients admitted to intensive care in selected time period

Exclusion Criteria:

  • Insufficient documentation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Paediatric patients 2008-2012
Paediatric patients admitted to intensive care in 2008-2012 who died during PICU stay
Other: Mortality
Patients who died during PICU stay
Paediatric patients 2013-2017
Paediatric patients admitted to intensive care in 2013-2017 who died during PICU stay
Other: Mortality
Patients who died during PICU stay

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Paediatric intesive care unit mortality
Time Frame: During Paediatric intesive care unit (PICU) stay Paediatric patients admitted to the intensive care in selected period (2008-2012. versus 2013-2017)
Mortality of paediatric patients in selected period in intensive care
During Paediatric intesive care unit (PICU) stay Paediatric patients admitted to the intensive care in selected period (2008-2012. versus 2013-2017)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Paediatric intesive care unit adjusted mortality
Time Frame: During Paediatric intesive care unit (PICU) stay Paediatric patients admitted to the intensive care in selected period (2008-2012. versus 2013-2017)
Mortality of paediatric patients in selected period in intensive care according to the admission diagnose and severity of disease
During Paediatric intesive care unit (PICU) stay Paediatric patients admitted to the intensive care in selected period (2008-2012. versus 2013-2017)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Brno University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2019

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

May 25, 2019

First Submitted That Met QC Criteria

May 30, 2019

First Posted (Actual)

May 31, 2019

Study Record Updates

Last Update Posted (Actual)

March 24, 2023

Last Update Submitted That Met QC Criteria

March 23, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • KDAR FN Brno 2019/4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morbidity, Multiple

Clinical Trials on Mortality

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe